119th Congress · HOUSE BILLBILL

H.R. 10628 — Biosimilars Access and Affordability Act

“To amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.”

Introduced Sep 28, 2026

Last action Sep 28, 2026

Pipeline · Bill → Law

Step 1

Introduced

Sep 28, 2026

Step 2

Referred

Sep 28, 2026

E&C · Ways & Means

Step 3

Committee

Step 4

House floor

Step 5

Senate

Step 6

Resolve Changes

Step 7

Signed

SummaryNo summary available

No CRS summary available for this bill.

Provisions · 2 sectionsIntroduced in House

AmendmentAI

Timeline · 2 actions

Sep 28, 2026

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Sep 28, 2026

Introduced in House